vimarsana.com

Page 33 - ஒன்றுபட்டது மாநிலங்களில் காப்புரிமை முத்திரை அலுவலகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tauriga Sciences Inc to Resume the Clinical Development of its Proposed

Share: This Proposed Pharma Grade Version of Tauri-Gum™ is Being Developed Specifically to Target: Patients Subjected to Ongoing Chemotherapy Treatment NEW YORK, NY, Dec. 16, 2020 (GLOBE NEWSWIRE) via NewMediaWire Tauriga Sciences, Inc. (OTCQB: TAUG) ( Tauriga or the Company ), a revenue generating, diversified life sciences company, with a proprietary line of functional supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced the resumption of clinical development efforts, concerning its proposed Anti-Nausea pharmaceutical grade version of Tauri-Gum™.  The Company expects to issue a material update to shareholders, within the near term (concerning the resumption of this Pharmaceutical Development Work).       

New WWE NXT Trademark, Raquel Gonzalez Says She Can t Be Stopped, Noam Dar s Supernova Sessions

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.